{
  "id": "everyday#risk_safety_51e8c22c",
  "title_en": "General — Risk Safety",
  "title_vi": "General — Nguy cơ An toàn",
  "text_en": "Are antidepressants (tricyclic antidepressants [TCAs] and selective serotonin reuptake inhibitors [SSRIs]) better than (more effective than/as safe as) pill placebo/treatment as usual in adults with depressive episode/disorder? Recommendation (update): In adults with moderate-to-severe depression, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine or sertraline (SSRIs) or amitriptyline (TCA) should be considered. Strength of recommendation: Conditional Certainty of evidence: Very low Justification cases where SSRIs are not available for adults with y Evidence was extracted from two meta-analyses: panic disorder. Cao et al., 2021 (42 RCTs) (129) and Cipriani et al., y TCAs should be avoided in older adults and in 2018 (522 RCTs) (130). people diagnosed with glaucoma, heart conditions, y SSRIs (namely citalopram, escitalopram, fluoxetine, prostatism or other prostate conditions, or at risk of fluvoxamine, paroxetine and sertraline) and TCAs these conditions. (namely amitriptyline) were significantly better than y Consider increased risk of bleeding associated pill placebo in reducing depressive symptoms. with SSRIs, particularly for older people or people y The certainties of evidence for change in depressive taking other medicines that can damage the symptoms, response, all-cause dropout, and gastrointestinal mucosa or interfere with clotting dropout due to adverse events were low for (e.g. NSAIDs). citalopram, escitalopram, fluoxetine, fluvoxamine, Research gaps paroxetine and sertraline (all SSRIs) and for y Most of the evidence is from HICs. Further research is amitriptyline (TCA). needed in LMICs. y Amitriptyline and fluoxetine are included in the WHO y There was no direct evidence to evaluate the risk of EML, with other SSRIs listed as alternatives (13). suicide-related adverse effects of antidepressants. Remarks Implementation considerations y The term “depression” refers to moderate to severe y Service providers should only consider depressive episode or disorder. antidepressant medicine alone for adults with y There were no studies identified in the review that depression when psychological interventions are included comparisons by severity of depression not available. (e.g. moderate versus severe). However, there y Service providers should assess psychosocial was no evidence of an association between stressors (e.g. domestic abuse, unemployment) baseline severity and the network estimates in associated with depression and include appropriate meta-regression analysis. psychosocial interventions in their treatment plan. y TCAs are generally less well tolerated than SSRIs y Providers should keep in mind the possible adverse and are also generally considered less safe, due to effects associated with antidepressants, the ability anticholinergic side-effects, toxicity, psychomotor to deliver either intervention (in terms of expertise and cognitive impairment risks, and lethality risks and/or treatment availability) and individual in cases of acute intoxication or overdose. TCAs preferences. Discontinuities in drug availability are therefore recommended for consideration in 58",
  "gloss_vi": "Are antidepressants (tricyclic antidepressants [tcas] and selective serotonin reuptake inhibitors [ssris]) better than (more effective than/as safe as) pill placebo/treatment as usual in adults with depressive episode/di...",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "risk_safety",
      "screening_cues",
      "referral",
      "do_not_do"
    ],
    "life_topics": [
      "stress",
      "work"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "high"
  },
  "index_text": "General — Risk Safety General — Nguy cơ An toàn Are antidepressants (tricyclic antidepressants [TCAs] and selective serotonin reuptake inhibitors [SSRIs]) better than (more effective than/as safe as) pill placebo/treatment as usual in adults with depressive episode/disorder? Recommendation (update): In adults with moderate-to-severe depression, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine or sertraline (SSRIs) or amitriptyline (TCA) should be considered. Strength of recommendation: Conditional Certainty of evidence: Very low Justification cases where SSRIs are not available for adults with y Evidence was extracted from two meta-analyses: panic disorder. Cao et al., 2021 (42 RCTs) (129) and Cipriani et al., y TCAs should be avoided in older adults and in 2018 (522 RCTs) (130). people diagnosed with glaucoma, heart conditions, y SSRIs (namely citalopram, escitalopram, fluoxetine, prostatism or other prostate conditions, or at risk of fluvoxamine, paroxetine and sertraline) and TCAs these conditions. (namely amitriptyline) were significantly better than y Consider increased risk of bleeding associated pill placebo in reducing depressive symptoms. with SSRIs, particularly for older people or people y The certainties of evidence for change in depressive taking other medicines that can damage the symptoms, response, all-cause dropout, and gastrointestinal mucosa or interfere with clotting dropout due to adverse events were low for (e.g. NSAIDs). citalopram, escitalopram, fluoxetine, fluvoxamine, Research gaps paroxetine and sertraline (all SSRIs) and for y Most of the evidence is from HICs. Further research is amitriptyline (TCA). needed in LMICs. y Amitriptyline and fluoxetine are included in the WHO y There was no direct evidence to evaluate the risk of EML, with other SSRIs listed as alternatives (13). suicide-related adverse effects of antidepressants. Remarks Implementation considerations y The term “depression” refers to moderate to severe y Service providers should only consider depressive episode or disorder. antidepressant medicine alone for adults with y There were no studies identified in the review that depression when psychological interventions are included comparisons by severity of depression not available. (e.g. moderate versus severe). However, there y Service providers should assess psychosocial was no evidence of an association between stressors (e.g. domestic abuse, unemployment) baseline severity and the network estimates in associated with depression and include appropriate meta-regression analysis. psychosocial interventions in their treatment plan. y TCAs are generally less well tolerated than SSRIs y Providers should keep in mind the possible adverse and are also generally considered less safe, due to effects associated with antidepressants, the ability anticholinergic side-effects, toxicity, psychomotor to deliver either intervention (in terms of expertise and cognitive impairment risks, and lethality risks and/or treatment availability) and individual in cases of acute intoxication or overdose. TCAs preferences. Discontinuities in drug availability are therefore recommended for consideration in 58 Are antidepressants (tricyclic antidepressants [tcas] and selective serotonin reuptake inhibitors [ssris]) better than (more effective than/as safe as) pill placebo/treatment as usual in adults with depressive episode/di..."
}